Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 985

Showing 1-25 of 985 citing articles:

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 654-656
Open Access | Times Cited: 1091
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 875
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 768
CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 307
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective
Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1738-1744
Closed Access | Times Cited: 291
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 420-424
Open Access | Times Cited: 246
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Sven Ullrich, Kasuni B. Ekanayake, Gottfried Otting, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 62, pp. 128629-128629
Open Access | Times Cited: 182
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
Eskild Petersen, Francine Ntoumi, David S.C. Hui, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 268-272
Open Access | Times Cited: 180
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021
Haogao Gu, Pavithra Krishnan, Daisy Y.M. Ng, et al.
Emerging infectious diseases (2021) Vol. 28, Iss. 2, pp. 460-462
Open Access | Times Cited: 179
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 177
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
Tyler N. Starr, Samantha K. Zepeda, Alexandra C. Walls, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 913-918
Open Access | Times Cited: 174
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Rebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 4, pp. 100583-100583
Open Access | Times Cited: 173
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
Peter V. Markov, Aris Katzourakis, Nikolaos I. Stilianakis
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 251-252
Open Access | Times Cited: 136
Drivers of adaptive evolution during chronic SARS-CoV-2 infections
Sheri Harari, Maayan Tahor, Natalie Rutsinsky, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1501-1508
Open Access | Times Cited: 131
Interferon resistance of emerging SARS-CoV-2 variants
Kejun Guo, Bradley S. Barrett, James H. Morrison, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 32
Open Access | Times Cited: 126
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
Catherine J. Reynolds, Joseph M. Gibbons, Corinna Pade, et al.
Science (2022) Vol. 375, Iss. 6577, pp. 183-192
Open Access | Times Cited: 121
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21
Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 821-834
Open Access | Times Cited: 117
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
Khalil El Karoui, An S. De Vriese
Kidney International (2022) Vol. 101, Iss. 5, pp. 883-894
Open Access | Times Cited: 116
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0261045-e0261045
Open Access | Times Cited: 94
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope
Garry Dolton, Cristina Rius, Md Samiul Hasan, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2936-2951.e19
Open Access | Times Cited: 88
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Hikmet Akkız
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 84
Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 84
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Chiara Pastorio, Fabian Zech, Sabrina Noettger, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 9, pp. 1255-1268.e5
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top